Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0YU2R
|
|||
Drug Name |
Pyrimidinyl compound 5
|
|||
Synonyms |
PMID26293650-Compound-40
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H25N7O
|
|||
Canonical SMILES |
C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CN=C(C=C4)N5CCOCC5)C#N
|
|||
InChI |
1S/C24H25N7O/c25-16-19-15-18(3-5-22(19)30-9-1-2-10-30)21-7-8-26-24(29-21)28-20-4-6-23(27-17-20)31-11-13-32-14-12-31/h3-8,15,17H,1-2,9-14H2,(H,26,28,29)
|
|||
InChIKey |
BEWCKABPPSBSRH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.